US major Illumina (NASDAQ: ILMN), which was included in a list of unreliable entities issued by China’s Ministry of Commerce (MOFCOM) earlier this year, has responded to the notice from MOFCOM on March 4, 2025. The company faces a prohibition on exporting sequencing instruments into China and has stated its respect for MOFCOM’s decision, emphasizing its commitment to complying with all applicable laws and regulations in every jurisdiction it operates in.
Business Adjustments and Future Plans
Despite the challenges posed by the export restrictions, Illumina remains focused on advancing its multiomics portfolio. The company plans to introduce new roadmap technologies spanning genomics, spatial, single cell, and methylation, as well as develop a new multimodal data analysis platform. These initiatives underscore Illumina’s dedication to innovation and expansion in the field of genomic research and applications.-Fineline Info & Tech
Leave a Reply